Drug Utilization Review (DUR) Board
The Drug Utilization Review (DUR) Board serves in an advisory capacity to the Department and makes recommendations regarding issues of drug utilization, provider education interventions, and application of standards. The Board meets once quarterly. The Board consists of nine members appointed by the Executive Director; four physicians, four pharmacists licensed and actively practicing in Colorado, and one non-voting pharmaceutical industry representative.
The DUR Board also determines the prior authorization criteria for drugs with special prescribing guidelines and the prior authorization criteria for non-preferred drugs, those that don't make the Preferred Drug List (PDL).
Presenting testimony
Interested parties that would like to present testimony to the DUR Board must sign up at least 24 hours in advance by contacting contact Jim Leonard at 303-866-3502 or Jim.Leonard@state.co.us
Attention Potential DUR Board Members
The Department is currently accepting curriculum vitae from potential DUR Board members. If you are interested in serving or know someone who would be qualified please submit a CV along with a completed Conflict of Interest form to Jim Leonard, 1570 Grant St., Denver, CO 80203, or fax to 303-866-3552 attn: Jim Leonard.
DUR Next Meeting
February 21, 2012
Closed Session: 6:00pm to 6:30pm
Open Session: 6:30pm - 9:00pm
225 E. 16th Avenue, 1st Floor Conference Room
Denver, CO 80203